Robeco Institutional Asset Management B.V. Increases Stake in Maximus, Inc. $MMS

Robeco Institutional Asset Management B.V. raised its stake in Maximus, Inc. (NYSE:MMS) by 64.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 29,644 shares of the health services provider’s stock after acquiring an additional 11,567 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.05% of Maximus worth $2,709,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Savant Capital LLC increased its holdings in shares of Maximus by 84.1% in the 2nd quarter. Savant Capital LLC now owns 10,055 shares of the health services provider’s stock worth $706,000 after buying an additional 4,594 shares during the last quarter. Magnetar Financial LLC boosted its holdings in shares of Maximus by 123.5% in the 2nd quarter. Magnetar Financial LLC now owns 12,774 shares of the health services provider’s stock worth $897,000 after purchasing an additional 7,059 shares during the period. Boston Partners increased its position in shares of Maximus by 113.6% during the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after purchasing an additional 349,529 shares during the last quarter. Deprince Race & Zollo Inc. raised its holdings in Maximus by 147.1% during the 3rd quarter. Deprince Race & Zollo Inc. now owns 243,695 shares of the health services provider’s stock valued at $22,266,000 after buying an additional 145,062 shares during the period. Finally, Creative Planning lifted its position in Maximus by 77.1% in the second quarter. Creative Planning now owns 37,582 shares of the health services provider’s stock worth $2,638,000 after buying an additional 16,363 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Insider Activity

In other news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the sale, the insider directly owned 19,542 shares in the company, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Maximus Trading Up 2.2%

Shares of NYSE:MMS opened at $97.00 on Friday. The business’s 50-day moving average is $85.50 and its 200 day moving average is $83.26. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $97.20. The firm has a market capitalization of $5.28 billion, a P/E ratio of 17.45 and a beta of 0.56.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.34 billion. During the same quarter in the previous year, the firm posted $1.46 EPS. Maximus’s revenue was up .2% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio (DPR) is currently 23.74%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.